Related references
Note: Only part of the references are listed.Protocol-Based Treatment of Hypertension A Critical Step on the Pathway to Progress
Thomas R. Frieden et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial
Colin P. Derdeyn et al.
LANCET (2014)
Blood Pressure After Recent Stroke: Baseline Findings From the Secondary Prevention of Small Subcortical Strokes Trial
Carole L. White et al.
AMERICAN JOURNAL OF HYPERTENSION (2013)
Why is controlling blood pressure after stroke so difficult?
Martin Dawes
CANADIAN MEDICAL ASSOCIATION JOURNAL (2013)
Clinical Features and Racial/Ethnic Differences Among the 3020 Participants in the Secondary Prevention of Small Subcortical Strokes (SPS3) Trial
Carole L. White et al.
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2013)
Blood-pressure targets in patients with recent lacunar stroke: the SPS3 randomised trial
O. R. Benavente et al.
LANCET (2013)
Predictors of lowering SBP to assigned targets at 12 months in the Secondary Prevention of Small Subcortical Strokes study
John W. Graves et al.
JOURNAL OF HYPERTENSION (2012)
Forecasting the Future of Cardiovascular Disease in the United States A Policy Statement From the American Heart Association
Paul A. Heidenreich et al.
CIRCULATION (2011)
Prevalence of Inadequate Blood Pressure Control Among Veterans After Acute Ischemic Stroke Hospitalization A Retrospective Cohort
Christianne L. Roumie et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2011)
The Secondary Prevention of Small Subcortical Strokes (SPS3) study
Oscar R. Benavente et al.
INTERNATIONAL JOURNAL OF STROKE (2011)
Impacting Population Cardiovascular Health Through a Community-Based Practice Network: Update on an ASH-Supported Collaborative
Brent M. Egan et al.
JOURNAL OF CLINICAL HYPERTENSION (2011)
Stroke Care 1 Medical treatment in acute and long-term secondary prevention after transient ischaemic attack and ischaemic stroke
Peter M. Rothwell et al.
LANCET (2011)
Effectiveness of a protocol-based strategy for achieving better blood pressure control in general practice
Marshall Godwin et al.
FAMILY PRACTICE (2010)
Awareness, Treatment, and Control of Vascular Risk Factors among Stroke Survivors
David A. Brenner et al.
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2010)
Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus
William C. Cushman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies
M. R. Law et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
Quality improvement strategies for hypertension management - A systematic review
Judith M. E. Walsh et al.
MEDICAL CARE (2006)
Racial and geographic differences in awareness, treatment, and control of hypertension - The REasons for geographic and racial differences in stroke study
G Howard et al.
STROKE (2006)
Racial disparities in hypertension prevalence, awareness, and management
RP Hertz et al.
ARCHIVES OF INTERNAL MEDICINE (2005)
Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA):: a multicentre randomised controlled trial
B Dahlöf et al.
LANCET (2005)
Clinical outcomes in antihypertensive treatment of type 2 diabetes, impaired fasting glucose concentration, and normoglycemia - Antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)
PK Whelton et al.
ARCHIVES OF INTERNAL MEDICINE (2005)
Outcomes in hypertensive black and nonblack patients treated with chlorthalidone, amlodipine, and lisinopril
JT Wright et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Recommendations for blood pressure measurement in humans and experimental animals - Part 1: Blood pressure measurement in humans - A statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research
TG Pickering et al.
HYPERTENSION (2005)
Atenolol in hypertension: is it a wise choice?
B Carlberg et al.
LANCET (2004)
Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial
S Julius et al.
LANCET (2004)
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure - The JNC 7 Report
AV Chobanian et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Blood pressure reduction and secondary prevention of stroke and other vascular events - A systematic review
P Rashid et al.
STROKE (2003)
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE):: a randomised trial against atenolol
B Dahlöf et al.
LANCET (2002)
Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack (Vol 358, pg 1033, 2001)
LANCET (2001)
Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack
S MacMahon et al.
LANCET (2001)
Share Paper
